![Sanjay Chanda](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sanjay Chanda
Corporate Officer/Principal bei AN2 THERAPEUTICS, INC.
Vermögen: 56 188 $ am 31.05.2024
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Eric Easom | M | 56 | 15 Jahre | |
Lucy Day | F | 65 | 20 Jahre | |
Douglas Giordano | M | 61 | 8 Jahre | |
Joseph Zakrzewski | M | 60 | 7 Jahre | |
Margaret M. Madden | F | - | 8 Jahre | |
Stephanie Wong | F | 50 | 3 Jahre | |
Josh Eizen | M | 46 | 2 Jahre | |
Gilbert Marks | M | 66 | 4 Jahre | |
Michael R. K. Alley | M | - | 7 Jahre | |
Kabeer Aziz | M | 34 | 5 Jahre | |
Robin Readnour | M | 60 | 5 Jahre | |
Gerard Pereira | M | - |
Cortene, Inc.
![]() Cortene, Inc. BiotechnologyHealth Technology Cortene, Inc. develops interventional treatment for myalgic encephalomyelitis. The company is headquartered in Burlingame, CA. | - |
Melvin Spigelman | M | 75 | 2 Jahre | |
Patricia Martin | F | 63 | 3 Jahre | |
Bryan Supran | M | - | 8 Jahre | |
Paul Eckburg | M | 54 | 5 Jahre | |
Maggie FitzPatrick | F | 58 | 2 Jahre | |
Carmen R. Rodriguez | F | 75 | 14 Jahre | |
Kevin Krause | M | 49 | 3 Jahre | |
Vincent Hernandez | M | - | 5 Jahre | |
Carole Nüchterlein | F | 62 |
Arch Oncology, Inc.
![]() Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | 8 Jahre |
Jennifer Huber | F | - | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Paul Berns | M | 57 | 4 Jahre | |
David Perry | M | 56 | 12 Jahre | |
Robert Karr | M | 75 |
Arch Oncology, Inc.
![]() Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | - |
Julie Cherrington | M | 66 |
Arch Oncology, Inc.
![]() Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | 3 Jahre |
Mark Leschly | M | 55 | 14 Jahre | |
Lucy Shapiro | M | 83 | 16 Jahre | |
John R. Donovan | M | - |
Arch Oncology, Inc.
![]() Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | 1 Jahre |
Zhi Hong | M | 60 | 2 Jahre | |
Graeme Bell | M | 57 | 1 Jahre | |
Keith Leonard | M | 62 | 2 Jahre | |
Ryan Sullivan | M | 48 | 2 Jahre | |
William Rieflin | M | 64 | 5 Jahre | |
Stephen Benkovic | M | - | 9 Jahre | |
Richard Markham | M | 73 | 7 Jahre | |
Wendell Wierenga | M | 76 | 2 Jahre | |
Anders Hove | M | 58 | 11 Jahre | |
Kurt Jarnagin | M | - | - | |
Vincent Ippolito | M | 65 | 3 Jahre | |
Christine E. Gray-Smith | F | - | 2 Jahre | |
Pankaj Bhargava | M | 54 |
Arch Oncology, Inc.
![]() Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | 1 Jahre |
Erik D. Wiberg | M | - | - | |
Michael Nazak | M | 66 | - | |
Geoffrey Parker | M | 59 | 6 Jahre | |
Lee T. Zane | M | 54 | - | |
Courtney Barton | F | 41 | 2 Jahre | |
Howie McKibbon | M | - | 3 Jahre | |
Annie Yoshiyama | F | 41 | 1 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 49 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Sanjay Chanda
- Persönliches Netzwerk